Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Creatine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 17/20 | 0.41 |
| ▸ | CA2 known ✓ | P00918 | 17/20 | 0.41 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Creatine SCHEMBL3816605 | 1.00 | CA1 (0.41) | CA1CA2NOS3NOS1NOS2 | |
| Creatine SCHEMBL5569335 | 0.95 | CA1 (0.41) | CA1CA2NOS3NOS1NOS2 | |
| Creatine SCHEMBL4885845 | 0.95 | CA1 (0.41) | CA1CA2NOS3NOS1NOS2 | |
| Creatine SCHEMBL3807770 | 0.95 | CA1 (0.41) | CA1CA2NOS3NOS1NOS2 | |
| Creatine SCHEMBL675800 | 0.95 | CA1 (0.41) | CA1CA2NOS3NOS1NOS2 | |
| Creatine SCHEMBL7858043 | 0.95 | CA1 (0.41) | CA1CA2NOS3NOS1NOS2 | |
| Creatine SCHEMBL6673726 | 0.95 | CA1 (0.41) | CA1CA2NOS3NOS1NOS2 | |
| Creatine SCHEMBL9391271 | 0.93 | CA1 (0.41) | CA1CA2NOS3NOS1NOS2 | |
| Creatine SCHEMBL1065566 | 0.92 | NOS3 (0.39) | CA1CA2NOS3NOS1NOS2 | |
| Creatine SCHEMBL939498 | 0.90 | CA1 (0.37) | CA1CA2NOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119662863-A | Kit for rapidly detecting helicobacter pylori and application | 上海北昂医药科技股份有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119592668-A | Probe for isothermal amplification and application thereof | 杭州迅灵生物科技有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119570918-A | RAA probe capable of being used for fluorescence detection and RAA-LFD detection and application thereof | 杭州迅灵生物科技有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119506402-A | Application of probe in multiplex amplification | 杭州迅灵生物科技有限公司 | 2025-02-25 | — | — | CN | disclosed |
| US-9114150-B2 | Stable aqueous compositions comprising bioactive creatine species | JHO INTELLECTUAL PROPERTY HOLDINGS, LLC (US) | 2015-08-25 | — | — | US | disclosed |
| US-20130143842-A1 | STABLE AQUEOUS COMPOSITIONS COMPRISING BIOACTIVE CREATINE SPECIES | ENERGY BEVERAGES LLC | 2013-06-06 | — | — | US | disclosed |
| US-8372821-B2 | Stable aqueous compositions comprising bioactive creatine species | ENERGY BEVERAGES LLC | 2013-02-12 | — | — | US | disclosed |
| US-20090257997-A1 | Stable Aqueous Compositions Comprising Bioactive Creatine Species | ENERGY BEVERAGES LLC | 2009-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130143842-A1 | STABLE AQUEOUS COMPOSITIONS COMPRISING BIOACTIVE CREATINE SPECIES | CKMT1A; CKMT1B, REN, PYGM | CA1 368/4885CA2 138/4885NOS3 1568/4885 |
| US-20090257997-A1 | Stable Aqueous Compositions Comprising Bioactive Creatine Species | CKMT1A; CKMT1B, REN, PYGM | CA1 425/4885CA2 204/4885NOS3 1291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.